Gray matter structural and molecular signatures in Alzheimer’s disease and late-life depression

The clinical distinction between Alzheimer’s disease and late-life depression has long represented one of the most significant hurdles in geriatric psychiatry and neurology. While the two conditions often present with…

Structural Signatures in Blood Proteins Offer New Hope for Early Alzheimer’s Detection

An estimated 7.2 million Americans aged 65 and older are currently living with Alzheimer’s disease, a figure that underscores the profound public health challenge posed by this neurodegenerative condition. For…